메뉴 건너뛰기
Infection and Immunity
Volumn 82, Issue 6, 2014, Pages 2574-2584
Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model
Author keywords

[No Author keywords available]
Indexed keywords

CHIMERIC PROTEIN; COMPLEMENT; IMMUNOGLOBULIN G; PORIN; PORIN B2; PORIN B3; UNCLASSIFIED DRUG; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; COMPLEMENT COMPONENT C3; FACTOR H-BINDING PROTEIN, NEISSERIA MENINGITIDIS; PORIN PROTEIN, NEISSERIA;
EID: 84900395918     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01517-14     Document Type: Article
Times cited : (19)
References (108)
  • 2
    • 77951429827 scopus 로고    scopus 로고
    • Advances in the development of vaccines against Neisseria meningitidis
    • Tan LK, Carlone GM, Borrow R. 2010. Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med. 362:1511-1520. http://dx.doi.org/10.1056/NEJMra0906357.
    • (2010) N. Engl. J. Med. , vol.362 , pp. 1511-1520
    • Tan, L.K.1    Carlone, G.M.2    Borrow, R.3
  • 3
    • 0027379446 scopus 로고
    • Complement deficiency states and meningococcal disease
    • Figueroa J, Andreoni J, Densen P. 1993. Complement deficiency states and meningococcal disease. Immunol. Res. 12:295-311. http://dx.doi.org/10.1007/BF02918259.
    • (1993) Immunol. Res. , vol.12 , pp. 295-311
    • Figueroa, J.1    Andreoni, J.2    Densen, P.3
  • 4
    • 78049408075 scopus 로고    scopus 로고
    • Infections of people with complement deficiencies and patients who have undergone splenectomy
    • Ram S, Lewis LA, Rice PA. 2010. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin. Microbiol. Rev. 23:740-780. http://dx.doi.org/10.1128/CMR.00048-09.
    • (2010) Clin. Microbiol. Rev. , vol.23 , pp. 740-780
    • Ram, S.1    Lewis, L.A.2    Rice, P.A.3
  • 5
    • 0018559386 scopus 로고
    • A molecular basis of activation of the alternative pathway of human complement
    • Austen KF, Fearon DT. 1979. A molecular basis of activation of the alternative pathway of human complement. Adv. Exp. Med. Biol. 120B: 3-17.
    • (1979) Adv. Exp. Med. Biol. , vol.120 B , pp. 3-17
    • Austen, K.F.1    Fearon, D.T.2
  • 6
    • 0016703811 scopus 로고
    • Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase
    • Fearon DT, Austen KF. 1975. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J. Exp. Med. 142:856-863. http://dx.doi.org/10.1084/jem.142.4.856.
    • (1975) J. Exp. Med. , vol.142 , pp. 856-863
    • Fearon, D.T.1    Austen, K.F.2
  • 7
    • 84857083353 scopus 로고    scopus 로고
    • Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor H binding protein
    • Giuntini S, Reason DC, Granoff DM. 2012. Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor H binding protein. Infect. Immun. 80:187-194. http://dx.doi.org/10.1128/IAI.05956-11.
    • (2012) Infect. Immun. , vol.80 , pp. 187-194
    • Giuntini, S.1    Reason, D.C.2    Granoff, D.M.3
  • 8
    • 77954315059 scopus 로고    scopus 로고
    • Complement control protein factor H: the good, the bad, and the inadequate
    • Ferreira VP, Pangburn MK, Cortes C. 2010. Complement control protein factor H: the good, the bad, and the inadequate. Mol. Immunol. 47:2187-2197. http://dx.doi.org/10.1016/j.molimm.2010.05.007.
    • (2010) Mol. Immunol. , vol.47 , pp. 2187-2197
    • Ferreira, V.P.1    Pangburn, M.K.2    Cortes, C.3
  • 9
    • 0011579669 scopus 로고
    • Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells
    • Pangburn MK, Muller-Eberhard HJ. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. U. S. A. 75:2416-2420. http://dx.doi.org/10.1073/pnas.75.5.2416.
    • (1978) Proc. Natl. Acad. Sci. U. S. A. , vol.75 , pp. 2416-2420
    • Pangburn, M.K.1    Muller-Eberhard, H.J.2
  • 10
    • 0017704496 scopus 로고
    • Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution
    • Pangburn MK, Schreiber RD, Muller-Eberhard HJ. 1977. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146:257-270. http://dx.doi.org/10.1084/jem.146.1.257.
    • (1977) J. Exp. Med. , vol.146 , pp. 257-270
    • Pangburn, M.K.1    Schreiber, R.D.2    Muller-Eberhard, H.J.3
  • 11
    • 0017139872 scopus 로고
    • Modulation of the alternative complement pathways by beta 1Hglobulin
    • Whaley K, Ruddy S. 1976. Modulation of the alternative complement pathways by beta 1Hglobulin. J. Exp. Med. 144:1147-1163. http://dx.doi.org/10.1084/jem.144.5.1147.
    • (1976) J. Exp. Med. , vol.144 , pp. 1147-1163
    • Whaley, K.1    Ruddy, S.2
  • 12
    • 0011188401 scopus 로고
    • Activation of the alternative complement pathway due to resistance of zymosan-bound
    • Fearon DT, Austen KF. 1977. Activation of the alternative complement pathway due to resistance of zymosan-bound. Proc. Natl. Acad. Sci. U. S. A. 74:1683-1687. http://dx.doi.org/10.1073/pnas.74.4.1683.
    • (1977) Proc. Natl. Acad. Sci. U. S. A. , vol.74 , pp. 1683-1687
    • Fearon, D.T.1    Austen, K.F.2
  • 13
    • 0012042656 scopus 로고
    • Control of the amplification convertase of complement by the plasma protein beta1H
    • Weiler JM, Daha MR, Austen KF, Fearon DT. 1976. Control of the amplification convertase of complement by the plasma protein beta1H. Proc. Natl. Acad. Sci. U. S. A. 73:3268-3272. http://dx.doi.org/10.1073/pnas.73.9.3268.
    • (1976) Proc. Natl. Acad. Sci. U. S. A. , vol.73 , pp. 3268-3272
    • Weiler, J.M.1    Daha, M.R.2    Austen, K.F.3    Fearon, D.T.4
  • 14
    • 0023085007 scopus 로고
    • Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation
    • Jarvis GA, Vedros NA. 1987. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect. Immun. 55:174-180.
    • (1987) Infect. Immun. , vol.55 , pp. 174-180
    • Jarvis, G.A.1    Vedros, N.A.2
  • 15
    • 79953142153 scopus 로고    scopus 로고
    • Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement
    • Ram S, Lewis LA, Agarwal S. 2011. Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement. J. Biol. Chem. 286:8297-8307. http://dx.doi.org/10.1074/jbc.M110.184838.
    • (2011) J. Biol. Chem. , vol.286 , pp. 8297-8307
    • Ram, S.1    Lewis, L.A.2    Agarwal, S.3
  • 16
    • 84861143541 scopus 로고    scopus 로고
    • The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci
    • Lewis LA, Carter M, Ram S. 2012. The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci. J. Immunol. 188:5063-5072. http://dx.doi.org/10.4049/jimmunol.1103748.
    • (2012) J. Immunol. , vol.188 , pp. 5063-5072
    • Lewis, L.A.1    Carter, M.2    Ram, S.3
  • 18
    • 77957652922 scopus 로고    scopus 로고
    • The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement
    • Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, Ram S. 2010. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog. 6:e1001027. http://dx.doi.org/10.1371/journal.ppat.1001027.
    • (2010) PLoS Pathog. , vol.6
    • Lewis, L.A.1    Ngampasutadol, J.2    Wallace, R.3    Reid, J.E.4    Vogel, U.5    Ram, S.6
  • 19
    • 84887153617 scopus 로고    scopus 로고
    • Factor H-Dependent Alternative Pathway Inhibition Mediated by Porin B Contributes to Virulence of Neisseria meningitidis
    • Lewis LA, Vu DM, Vasudhev S, Shaughnessy J, Granoff DM, Ram S. 2013. Factor H-Dependent Alternative Pathway Inhibition Mediated by Porin B Contributes to Virulence of Neisseria meningitidis. mBio 4(5): e00339-13. http://dx.doi.org/10.1128/mBio.00339-13.
    • (2013) mBio , vol.4 , Issue.5
    • Lewis, L.A.1    Vu, D.M.2    Vasudhev, S.3    Shaughnessy, J.4    Granoff, D.M.5    Ram, S.6
  • 20
    • 0023927044 scopus 로고
    • Experimental meningococcal meningitis in the infant rat
    • Saukkonen K. 1988. Experimental meningococcal meningitis in the infant rat. Microb. Pathog. 4:203-211. http://dx.doi.org/10.1016/0882-4010(88)90070-8.
    • (1988) Microb. Pathog. , vol.4 , pp. 203-211
    • Saukkonen, K.1
  • 21
    • 84857144559 scopus 로고    scopus 로고
    • Enhanced bacteremia in human factorHtransgenic rats infected by Neisseria meningitidis
    • Vu DM, Shaughnessy J, Lewis LA, Ram S, Rice PA, Granoff DM. 2012. Enhanced bacteremia in human factorHtransgenic rats infected by Neisseria meningitidis. Infect. Immun. 80:643-650. http://dx.doi.org/10.1128/IAI.05604-11.
    • (2012) Infect. Immun. , vol.80 , pp. 643-650
    • Vu, D.M.1    Shaughnessy, J.2    Lewis, L.A.3    Ram, S.4    Rice, P.A.5    Granoff, D.M.6
  • 22
    • 0041522311 scopus 로고    scopus 로고
    • Identification of the hypervirulent lineages of Neisseria meningitidis, the ST-8 and ST-11 complexes, by using monoclonal antibodies specific to NmeDI
    • Claus H, Weinand H, Frosch M, Vogel U. 2003. Identification of the hypervirulent lineages of Neisseria meningitidis, the ST-8 and ST-11 complexes, by using monoclonal antibodies specific to NmeDI. J. Clin. Microbiol. 41:3873-3876. http://dx.doi.org/10.1128/JCM.41.8.3873-3876.2003.
    • (2003) J. Clin. Microbiol. , vol.41 , pp. 3873-3876
    • Claus, H.1    Weinand, H.2    Frosch, M.3    Vogel, U.4
  • 23
    • 4644258172 scopus 로고    scopus 로고
    • Naturally acquired passive protective activity against Neisseria meningitidis group C in the absence of serum bactericidal activity
    • Welsch JA, Granoff D. 2004. Naturally acquired passive protective activity against Neisseria meningitidis group C in the absence of serum bactericidal activity. Infect. Immun. 72:5903-5909. http://dx.doi.org/10.1128/IAI.72.10.5903-5909.2004.
    • (2004) Infect. Immun. , vol.72 , pp. 5903-5909
    • Welsch, J.A.1    Granoff, D.2
  • 24
    • 24144447287 scopus 로고    scopus 로고
    • Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines
    • Toropainen M, Saarinen L, Wedege E, Bolstad K, Makela PH, Kayhty H. 2005. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines. Vaccine 23:4821-4833. http://dx.doi.org/10.1016/j.vaccine.2005.05.005.
    • (2005) Vaccine , vol.23 , pp. 4821-4833
    • Toropainen, M.1    Saarinen, L.2    Wedege, E.3    Bolstad, K.4    Makela, P.H.5    Kayhty, H.6
  • 25
    • 60549113322 scopus 로고    scopus 로고
    • Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera
    • Granoff DM, Welsch JA, Ram S. 2009. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect. Immun. 77:764-769. http://dx.doi.org/10.1128/IAI.01191-08.
    • (2009) Infect. Immun. , vol.77 , pp. 764-769
    • Granoff, D.M.1    Welsch, J.A.2    Ram, S.3
  • 26
    • 79955426754 scopus 로고    scopus 로고
    • Whole-genome sequence of the transformable Neisseria meningitidis serogroup A strain WUE2594
    • Schoen C, Weber-Lehmann J, Blom J, Joseph B, Goesmann A, Strittmatter A, Frosch M. 2011. Whole-genome sequence of the transformable Neisseria meningitidis serogroup A strain WUE2594. J. Bacteriol. 193:2064-2065. http://dx.doi.org/10.1128/JB.00084-11.
    • (2011) J. Bacteriol. , vol.193 , pp. 2064-2065
    • Schoen, C.1    Weber-Lehmann, J.2    Blom, J.3    Joseph, B.4    Goesmann, A.5    Strittmatter, A.6    Frosch, M.7
  • 27
    • 0342827809 scopus 로고
    • Proposed schema for identification of serotypes of Neisseria meningitidis
    • Schoolnik G (ed), American Society for Microbiology, Washington, DC.
    • Frasch C, Zollinger W, Poolman J. 1985. Proposed schema for identification of serotypes of Neisseria meningitidis, p 519-524. In Schoolnik G (ed), The pathogenic Neisseria. American Society for Microbiology, Washington, DC.
    • (1985) The pathogenic Neisseria , pp. 519-524
    • Frasch, C.1    Zollinger, W.2    Poolman, J.3
  • 28
    • 0031906952 scopus 로고    scopus 로고
    • New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4
    • Martin DR, Walker SJ, Baker MG, Lennon DR. 1998. New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J. Infect. Dis. 177:497-500. http://dx.doi.org/10.1086/517385.
    • (1998) J. Infect. Dis. , vol.177 , pp. 497-500
    • Martin, D.R.1    Walker, S.J.2    Baker, M.G.3    Lennon, D.R.4
  • 29
    • 2142828652 scopus 로고    scopus 로고
    • Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine
    • Welsch JA, Rossi R, Comanducci M, Granoff DM. 2004. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine. J. Immunol. 172:5606-5615.
    • (2004) J. Immunol. , vol.172 , pp. 5606-5615
    • Welsch, J.A.1    Rossi, R.2    Comanducci, M.3    Granoff, D.M.4
  • 30
    • 0031851907 scopus 로고    scopus 로고
    • Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts
    • Vogel U, Morelli G, Zurth K, Claus H, Kriener E, Achtman M, Frosch M. 1998. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J. Clin. Microbiol. 36:2465-2470.
    • (1998) J. Clin. Microbiol. , vol.36 , pp. 2465-2470
    • Vogel, U.1    Morelli, G.2    Zurth, K.3    Claus, H.4    Kriener, E.5    Achtman, M.6    Frosch, M.7
  • 32
    • 0034003912 scopus 로고    scopus 로고
    • Meningococcal disease in Dallas County, Texas: results of a six-year population-based study
    • Pastor P, Medley FB, Murphy TV. 2000. Meningococcal disease in Dallas County, Texas: results of a six-year population-based study. Pediatr. Infect. Dis. J. 19:324-328. http://dx.doi.org/10.1097/00006454-2000 04000-00012.
    • (2000) Pediatr. Infect. Dis. J. , vol.19 , pp. 324-328
    • Pastor, P.1    Medley, F.B.2    Murphy, T.V.3
  • 34
    • 33947661030 scopus 로고    scopus 로고
    • Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin
    • Madico G, Ngampasutadol J, Gulati S, Vogel U, Rice PA, Ram S. 2007. Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin. J. Immunol. 178: 4489-4497.
    • (2007) J. Immunol. , vol.178 , pp. 4489-4497
    • Madico, G.1    Ngampasutadol, J.2    Gulati, S.3    Vogel, U.4    Rice, P.A.5    Ram, S.6
  • 35
  • 36
    • 65449172045 scopus 로고    scopus 로고
    • Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin
    • Shaughnessy J, Lewis LA, Jarva H, Ram S. 2009. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin. Infect. Immun. 77:2094-2103. http://dx.doi.org/10.1128/IAI.01561-08.
    • (2009) Infect. Immun. , vol.77 , pp. 2094-2103
    • Shaughnessy, J.1    Lewis, L.A.2    Jarva, H.3    Ram, S.4
  • 37
    • 3042543916 scopus 로고    scopus 로고
    • Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine
    • Granoff DM, Harris SL. 2004. Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine. Pediatr. Infect. Dis. J. 23:490-497. http://dx.doi.org/10.1097/01.inf.0000129686.12470.e6.
    • (2004) Pediatr. Infect. Dis. J. , vol.23 , pp. 490-497
    • Granoff, D.M.1    Harris, S.L.2
  • 38
    • 0035024481 scopus 로고    scopus 로고
    • Functional activity of anti-neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B
    • Moe GR, Zuno-Mitchell P, Lee SS, Lucas AH, Granoff DM. 2001. Functional activity of anti-neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B. Infect. Immun. 69: 3762-3771. http://dx.doi.org/10.1128/IAI.69.6.3762-3771.2001.
    • (2001) Infect. Immun. , vol.69 , pp. 3762-3771
    • Moe, G.R.1    Zuno-Mitchell, P.2    Lee, S.S.3    Lucas, A.H.4    Granoff, D.M.5
  • 39
    • 0346256759 scopus 로고    scopus 로고
    • Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
    • Welsch JA, Moe GR, Rossi R, Adu-Bobie J, Rappuoli R, Granoff DM. 2003. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity. J. Infect. Dis. 188:1730-1740. http://dx.doi.org/10.1086/379375.
    • (2003) J. Infect. Dis. , vol.188 , pp. 1730-1740
    • Welsch, J.A.1    Moe, G.R.2    Rossi, R.3    Adu-Bobie, J.4    Rappuoli, R.5    Granoff, D.M.6
  • 40
    • 0035112040 scopus 로고    scopus 로고
    • Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection
    • Borrow R, Andrews N, Goldblatt D, Miller E. 2001. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect. Immun. 69: 1568-1573. http://dx.doi.org/10.1128/IAI.69.3.1568-1573.2001.
    • (2001) Infect. Immun. , vol.69 , pp. 1568-1573
    • Borrow, R.1    Andrews, N.2    Goldblatt, D.3    Miller, E.4
  • 42
    • 84864546846 scopus 로고    scopus 로고
    • Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction
    • Ishola DA, Jr, Borrow R, Findlow H, Findlow J, Trotter C, Ramsay ME. 2012. Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction. Clin. Vaccine Immunol. 19:1126-1130. http://dx.doi.org/10.1128/CVI.05655-11.
    • (2012) Clin. Vaccine Immunol. , vol.19 , pp. 1126-1130
    • Ishola Jr., D.A.1    Borrow, R.2    Findlow, H.3    Findlow, J.4    Trotter, C.5    Ramsay, M.E.6
  • 43
    • 0033033505 scopus 로고    scopus 로고
    • FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function
    • Zipfel PF, Skerka C. 1999. FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function. Immunol. Today 20:135-140. http://dx.doi.org/10.1016/S0167-5699(98)01432-7.
    • (1999) Immunol. Today , vol.20 , pp. 135-140
    • Zipfel, P.F.1    Skerka, C.2
  • 44
    • 0037218599 scopus 로고    scopus 로고
    • Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine
    • Harris SL, King WJ, Ferris W, Granoff DM. 2003. Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine. Infect. Immun. 71: 275-286. http://dx.doi.org/10.1128/IAI.71.1.275-286.2003.
    • (2003) Infect. Immun. , vol.71 , pp. 275-286
    • Harris, S.L.1    King, W.J.2    Ferris, W.3    Granoff, D.M.4
  • 45
    • 0023681391 scopus 로고
    • Monoclonal antibodies to the rough lipopolysaccharide of Neisseria meningitidis protect infant rats from meningococcal infection
    • Saukkonen K, Leinonen M, Kayhty H, Abdillahi H, Poolman JT. 1988. Monoclonal antibodies to the rough lipopolysaccharide of Neisseria meningitidis protect infant rats from meningococcal infection. J. Infect. Dis. 158:209-212. http://dx.doi.org/10.1093/infdis/158.1.209.
    • (1988) J. Infect. Dis. , vol.158 , pp. 209-212
    • Saukkonen, K.1    Leinonen, M.2    Kayhty, H.3    Abdillahi, H.4    Poolman, J.T.5
  • 46
    • 0034978482 scopus 로고    scopus 로고
    • Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model
    • Toropainen M, Saarinen L, van der Ley P, Kuipers B, Kayhty H. 2001. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model. Microb. Pathog. 30:139-148. http://dx.doi.org/10.1006/mpat.2000.0419.
    • (2001) Microb. Pathog. , vol.30 , pp. 139-148
    • Toropainen, M.1    Saarinen, L.2    van der Ley, P.3    Kuipers, B.4    Kayhty, H.5
  • 47
    • 84891649590 scopus 로고    scopus 로고
    • Meningococcal disease and the complement system
    • Lewis LA, Ram S. 2014. Meningococcal disease and the complement system. Virulence 5:98-126. http://dx.doi.org/10.4161/viru.26515.
    • (2014) Virulence , vol.5 , pp. 98-126
    • Lewis, L.A.1    Ram, S.2
  • 48
    • 0037320106 scopus 로고    scopus 로고
    • The role of porins in neisserial pathogenesis and immunity
    • Massari P, Ram S, Macleod H, Wetzler LM. 2003. The role of porins in neisserial pathogenesis and immunity. Trends Microbiol. 11:87-93. http://dx.doi.org/10.1016/S0966-842X(02)00037-9.
    • (2003) Trends Microbiol. , vol.11 , pp. 87-93
    • Massari, P.1    Ram, S.2    Macleod, H.3    Wetzler, L.M.4
  • 49
    • 77951057326 scopus 로고    scopus 로고
    • Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB
    • Tanabe M, Nimigean CM, Iverson TM. 2010. Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB. Proc. Natl. Acad. Sci. U. S. A. 107:6811-6816. http://dx.doi.org/10.1073/pnas.0912115107.
    • (2010) Proc. Natl. Acad. Sci. U. S. A. , vol.107 , pp. 6811-6816
    • Tanabe, M.1    Nimigean, C.M.2    Iverson, T.M.3
  • 50
    • 79958017248 scopus 로고    scopus 로고
    • Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factorHbinding protein
    • Lucidarme J, Tan L, Exley RM, Findlow J, Borrow R, Tang CM. 2011. Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factorHbinding protein. Clin. Vaccine Immunol. 18:1002-1014. http://dx.doi.org/10.1128/CVI.00055-11.
    • (2011) Clin. Vaccine Immunol. , vol.18 , pp. 1002-1014
    • Lucidarme, J.1    Tan, L.2    Exley, R.M.3    Findlow, J.4    Borrow, R.5    Tang, C.M.6
  • 51
    • 84881551209 scopus 로고    scopus 로고
    • fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations
    • Giuntini S, Vu DM, Granoff DM. 2013. fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations. Vaccine 31:4192-4199. http://dx.doi.org/10.1016/j.vaccine.2013.06.009.
    • (2013) Vaccine , vol.31 , pp. 4192-4199
    • Giuntini, S.1    Vu, D.M.2    Granoff, D.M.3
  • 52
    • 0027158675 scopus 로고
    • The interaction of primate transferrins with receptors on bacteria pathogenic to humans
    • Gray-Owen SD, Schryvers AB. 1993. The interaction of primate transferrins with receptors on bacteria pathogenic to humans. Microb. Pathog. 14:389-398. http://dx.doi.org/10.1006/mpat.1993.1038.
    • (1993) Microb. Pathog. , vol.14 , pp. 389-398
    • Gray-Owen, S.D.1    Schryvers, A.B.2
  • 53
    • 0024118398 scopus 로고
    • Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae
    • Lee BC, Schryvers AB. 1988. Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae. Mol. Microbiol. 2:827-829. http://dx.doi.org/10.1111/j.1365-2958.1988.tb00095.x.
    • (1988) Mol. Microbiol. , vol.2 , pp. 827-829
    • Lee, B.C.1    Schryvers, A.B.2
  • 54
    • 0030965374 scopus 로고    scopus 로고
    • CD66 carcinoembryonic antigens mediate interactions between Opaexpressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes
    • Gray-Owen SD, Dehio C, Haude A, Grunert F, Meyer TF. 1997. CD66 carcinoembryonic antigens mediate interactions between Opaexpressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. EMBO J. 16:3435-3445. http://dx.doi.org/10.1093/emboj/16.12.3435.
    • (1997) EMBO J. , vol.16 , pp. 3435-3445
    • Gray-Owen, S.D.1    Dehio, C.2    Haude, A.3    Grunert, F.4    Meyer, T.F.5
  • 55
    • 77956321361 scopus 로고    scopus 로고
    • Generation of human CEACAM1 transgenic mice and binding of Neisseria Opa protein to their neutrophils
    • Gu A, Zhang Z, Zhang N, Tsark W, Shively JE. 2010. Generation of human CEACAM1 transgenic mice and binding of Neisseria Opa protein to their neutrophils. PLoS One 5:e10067. http://dx.doi.org/10.1371/journal.pone.0010067.
    • (2010) PLoS One , vol.5
    • Gu, A.1    Zhang, Z.2    Zhang, N.3    Tsark, W.4    Shively, J.E.5
  • 57
    • 84900459343 scopus 로고    scopus 로고
    • Heterogeneity of binding of rhesus macaque factor H to meningococcal factor H binding protein
    • poster 287, Wurzburg, Germany, 9 to 14 September 2012.
    • Granoff D, Shaughnessy J, Beernink PT, Vasudhev S, Santos G, Ram S. 2012. Heterogeneity of binding of rhesus macaque factor H to meningococcal factor H binding protein, poster 287, p 438. Abstr. XVIIIth Int. Pathog. Neisseria Conf., Wurzburg, Germany, 9 to 14 September 2012.
    • (2012) Abstr. XVIIIth Int. Pathog. Neisseria Conf. , pp. 438
    • Granoff, D.1    Shaughnessy, J.2    Beernink, P.T.3    Vasudhev, S.4    Santos, G.5    Ram, S.6
  • 59
    • 65449172051 scopus 로고    scopus 로고
    • The RNA chaperone Hfq is involved in stress response and virulence in Neisseria meningitidis and is a pleiotropic regulator of protein expression
    • Fantappie L, Metruccio MM, Seib KL, Oriente F, Cartocci E, Ferlicca F, Giuliani MM, Scarlato V, Delany I. 2009. The RNA chaperone Hfq is involved in stress response and virulence in Neisseria meningitidis and is a pleiotropic regulator of protein expression. Infect. Immun. 77:1842-1853. http://dx.doi.org/10.1128/IAI.01216-08.
    • (2009) Infect. Immun. , vol.77 , pp. 1842-1853
    • Fantappie, L.1    Metruccio, M.M.2    Seib, K.L.3    Oriente, F.4    Cartocci, E.5    Ferlicca, F.6    Giuliani, M.M.7    Scarlato, V.8    Delany, I.9
  • 62
    • 0023552097 scopus 로고
    • Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development
    • Saukkonen K, Abdillahi H, Poolman JT, Leinonen M. 1987. Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microb. Pathog. 3:261-267. http://dx.doi.org/10.1016/0882-4010(87)90059-3.
    • (1987) Microb. Pathog. , vol.3 , pp. 261-267
    • Saukkonen, K.1    Abdillahi, H.2    Poolman, J.T.3    Leinonen, M.4
  • 63
    • 13844298295 scopus 로고    scopus 로고
    • Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine
    • Granoff DM, Morgan A, Welsch JA. 2005. Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine. Pediatr. Infect. Dis. J. 24:132-136. http://dx.doi.org/10.1097/01.inf.0000151035.64356.f8.
    • (2005) Pediatr. Infect. Dis. J. , vol.24 , pp. 132-136
    • Granoff, D.M.1    Morgan, A.2    Welsch, J.A.3
  • 64
    • 0037767171 scopus 로고    scopus 로고
    • Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidisdiphtheria toxoid conjugate vaccine and by a polysaccharide vaccine
    • Harris SL, Finn A, Granoff DM. 2003. Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidisdiphtheria toxoid conjugate vaccine and by a polysaccharide vaccine. Infect. Immun. 71:3402-3408. http://dx.doi.org/10.1128/IAI.71.6.3402-3408.2003.
    • (2003) Infect. Immun. , vol.71 , pp. 3402-3408
    • Harris, S.L.1    Finn, A.2    Granoff, D.M.3
  • 66
    • 33746126484 scopus 로고    scopus 로고
    • Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization
    • Vu DM, Kelly D, Heath PT, McCarthy ND, Pollard AJ, Granoff DM. 2006. Effectiveness analyses may underestimate protection of infants after group C meningococcal immunization. J. Infect. Dis. 194:231-237. http://dx.doi.org/10.1086/505077.
    • (2006) J. Infect. Dis. , vol.194 , pp. 231-237
    • Vu, D.M.1    Kelly, D.2    Heath, P.T.3    McCarthy, N.D.4    Pollard, A.J.5    Granoff, D.M.6
  • 67
    • 33644884439 scopus 로고    scopus 로고
    • Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine
    • Vu DM, Welsch JA, Zuno-Mitchell P, Dela Cruz JV, Granoff DM. 2006. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine. J. Infect. Dis. 193: 821-828. http://dx.doi.org/10.1086/500512.
    • (2006) J. Infect. Dis. , vol.193 , pp. 821-828
    • Vu, D.M.1    Welsch, J.A.2    Zuno-Mitchell, P.3    Dela Cruz, J.V.4    Granoff, D.M.5
  • 68
    • 55849104814 scopus 로고    scopus 로고
    • Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype
    • Bayliss CD, Hoe JC, Makepeace K, Martin P, Hood DW, Moxon ER. 2008. Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype. Infect. Immun. 76:5038-5048. http://dx.doi.org/10.1128/IAI.00395-08.
    • (2008) Infect. Immun. , vol.76 , pp. 5038-5048
    • Bayliss, C.D.1    Hoe, J.C.2    Makepeace, K.3    Martin, P.4    Hood, D.W.5    Moxon, E.R.6
  • 69
    • 24944524918 scopus 로고    scopus 로고
    • Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits
    • Cox AD, Zou W, Gidney MA, Lacelle S, Plested JS, Makepeace K, Wright JC, Coull PA, Moxon ER, Richards JC. 2005. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits. Vaccine 23:5045-5054. http://dx.doi.org/10.1016/j.vaccine.2005.06.011.
    • (2005) Vaccine , vol.23 , pp. 5045-5054
    • Cox, A.D.1    Zou, W.2    Gidney, M.A.3    Lacelle, S.4    Plested, J.S.5    Makepeace, K.6    Wright, J.C.7    Coull, P.A.8    Moxon, E.R.9    Richards, J.C.10
  • 71
    • 0032706010 scopus 로고    scopus 로고
    • Differences in surface expression of NspA among Neisseria meningitidis group B strains
    • Moe GR, Tan S, Granoff DM. 1999. Differences in surface expression of NspA among Neisseria meningitidis group B strains. Infect. Immun. 67: 5664-5675.
    • (1999) Infect. Immun. , vol.67 , pp. 5664-5675
    • Moe, G.R.1    Tan, S.2    Granoff, D.M.3
  • 72
    • 1842536399 scopus 로고    scopus 로고
    • GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence
    • Adu-Bobie J, Lupetti P, Brunelli B, Granoff D, Norais N, Ferrari G, Grandi G, Rappuoli R, Pizza M. 2004. GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence. Infect. Immun. 72:1914-1919. http://dx.doi.org/10.1128/IAI.72.4.1914-1919.2004.
    • (2004) Infect. Immun. , vol.72 , pp. 1914-1919
    • Adu-Bobie, J.1    Lupetti, P.2    Brunelli, B.3    Granoff, D.4    Norais, N.5    Ferrari, G.6    Grandi, G.7    Rappuoli, R.8    Pizza, M.9
  • 74
    • 0036841444 scopus 로고    scopus 로고
    • Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains
    • Moe GR, Zuno-Mitchell P, Hammond SN, Granoff DM. 2002. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains. Infect. Immun. 70:6021-6031. http://dx.doi.org/10.1128/IAI.70.11.6021-6031.2002.
    • (2002) Infect. Immun. , vol.70 , pp. 6021-6031
    • Moe, G.R.1    Zuno-Mitchell, P.2    Hammond, S.N.3    Granoff, D.M.4
  • 75
    • 0032957239 scopus 로고    scopus 로고
    • Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates
    • Vogel U, Claus H, Heinze G, Frosch M. 1999. Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. Infect. Immun. 67:954-957.
    • (1999) Infect. Immun. , vol.67 , pp. 954-957
    • Vogel, U.1    Claus, H.2    Heinze, G.3    Frosch, M.4
  • 76
    • 77952365730 scopus 로고    scopus 로고
    • Vaccines containing de-Nacetyl sialic acid elicit antibodies protective against Neisseria meningitidis groups B and C
    • Moe GR, Bhandari TS, Flitter BA. 2009. Vaccines containing de-Nacetyl sialic acid elicit antibodies protective against Neisseria meningitidis groups B and C. J. Immunol. 182:6610-6617. http://dx.doi.org/10.4049/jimmunol.0803677.
    • (2009) J. Immunol. , vol.182 , pp. 6610-6617
    • Moe, G.R.1    Bhandari, T.S.2    Flitter, B.A.3
  • 77
    • 0030814745 scopus 로고    scopus 로고
    • Cloning and characterization of the Neisseria meningitidis rfaC gene encoding alpha-1,5 heptosyltransferase I
    • Stojiljkovic I, Hwa V, Larson J, Lin L, So M, Nassif X. 1997. Cloning and characterization of the Neisseria meningitidis rfaC gene encoding alpha-1,5 heptosyltransferase I. FEMS Microbiol. Lett. 151:41-49. http://dx.doi.org/10.1016/S0378-1097(97)00135-3.
    • (1997) FEMS Microbiol. Lett. , vol.151 , pp. 41-49
    • Stojiljkovic, I.1    Hwa, V.2    Larson, J.3    Lin, L.4    So, M.5    Nassif, X.6
  • 78
    • 0028968322 scopus 로고
    • The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence
    • Stojiljkovic I, Hwa V, de Saint Martin L, O'Gaora P, Nassif X, Heffron F, So M. 1995. The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence. Mol. Microbiol. 15:531-541. http://dx.doi.org/10.1111/j.1365-2958.1995.tb02266.x.
    • (1995) Mol. Microbiol. , vol.15 , pp. 531-541
    • Stojiljkovic, I.1    Hwa, V.2    de Saint Martin, L.3    O'Gaora, P.4    Nassif, X.5    Heffron, F.6    So, M.7
  • 79
    • 0024309455 scopus 로고
    • Antibody production to a meningococcal outer membrane protein cloned into live Salmonella typhimurium aroA vaccine strain
    • Tarkka E, Muotiala A, Karvonen M, Saukkonen-Laitinen K, Sarvas M. 1989. Antibody production to a meningococcal outer membrane protein cloned into live Salmonella typhimurium aroA vaccine strain. Microb. Pathog. 6:327-335. http://dx.doi.org/10.1016/0882-4010(89)90074-0.
    • (1989) Microb. Pathog. , vol.6 , pp. 327-335
    • Tarkka, E.1    Muotiala, A.2    Karvonen, M.3    Saukkonen-Laitinen, K.4    Sarvas, M.5
  • 81
    • 80051934372 scopus 로고    scopus 로고
    • Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst
    • Tala A, Monaco C, Nagorska K, Exley RM, Corbett A, Zychlinsky A, Alifano P, Tang CM. 2011. Glutamate utilization promotes meningococcal survival in vivo through avoidance of the neutrophil oxidative burst. Mol. Microbiol. 81:1330-1342. http://dx.doi.org/10.1111/j.1365-2958.2011.07766.x.
    • (2011) Mol. Microbiol. , vol.81 , pp. 1330-1342
    • Tala, A.1    Monaco, C.2    Nagorska, K.3    Exley, R.M.4    Corbett, A.5    Zychlinsky, A.6    Alifano, P.7    Tang, C.M.8
  • 82
    • 0035860608 scopus 로고    scopus 로고
    • Passive immunization with Neisseria meningitidis PorA specific immune sera reduces nasopharyngeal colonization of group B meningococcus in an infant rat nasal challenge model
    • Schmidt S, Zhu D, Barniak V, Mason K, Zhang Y, Arumugham R, Metcalf T. 2001. Passive immunization with Neisseria meningitidis PorA specific immune sera reduces nasopharyngeal colonization of group B meningococcus in an infant rat nasal challenge model. Vaccine 19:4851-4858. http://dx.doi.org/10.1016/S0264-410X(01)00229-8.
    • (2001) Vaccine , vol.19 , pp. 4851-4858
    • Schmidt, S.1    Zhu, D.2    Barniak, V.3    Mason, K.4    Zhang, Y.5    Arumugham, R.6    Metcalf, T.7
  • 83
    • 25444523998 scopus 로고    scopus 로고
    • Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model
    • Zhu D, Zhang Y, Barniak V, Bernfield L, Howell A, Zlotnick G. 2005. Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model. Infect. Immun. 73:6838-6845. http://dx.doi.org/10.1128/IAI.73.10.6838-6845.2005.
    • (2005) Infect. Immun. , vol.73 , pp. 6838-6845
    • Zhu, D.1    Zhang, Y.2    Barniak, V.3    Bernfield, L.4    Howell, A.5    Zlotnick, G.6
  • 84
    • 23344443340 scopus 로고    scopus 로고
    • Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis
    • Toropainen M, Saarinen L, Wedege E, Bolstad K, Michaelsen TE, Aase A, Kayhty H. 2005. Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis. Infect. Immun. 73:4694-4703. http://dx.doi.org/10.1128/IAI.73.8.4694-4703.2005.
    • (2005) Infect. Immun. , vol.73 , pp. 4694-4703
    • Toropainen, M.1    Saarinen, L.2    Wedege, E.3    Bolstad, K.4    Michaelsen, T.E.5    Aase, A.6    Kayhty, H.7
  • 85
    • 33646368658 scopus 로고    scopus 로고
    • Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant rats
    • Toropainen M, Saarinen L, Vidarsson G, Kayhty H. 2006. Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant rats. Infect. Immun. 74:2803-2808. http://dx.doi.org/10.1128/IAI.74.5.2803-2808.2006.
    • (2006) Infect. Immun. , vol.74 , pp. 2803-2808
    • Toropainen, M.1    Saarinen, L.2    Vidarsson, G.3    Kayhty, H.4
  • 88
    • 10444251010 scopus 로고    scopus 로고
    • Immunization of mice with Neisseria meningitidis serogroup B genomic expression libraries elicits functional antibodies and reduces the level of bacteremia in an infant rat infection model
    • Yero CD, Pajon FR, Caballero ME, Cobas AK, Lopez HY, Farinas MM, Gonzales BS, Acosta DA. 2005. Immunization of mice with Neisseria meningitidis serogroup B genomic expression libraries elicits functional antibodies and reduces the level of bacteremia in an infant rat infection model. Vaccine 23:932-939. http://dx.doi.org/10.1016/j.vaccine.2004.07.032.
    • (2005) Vaccine , vol.23 , pp. 932-939
    • Yero, C.D.1    Pajon, F.R.2    Caballero, M.E.3    Cobas, A.K.4    Lopez, H.Y.5    Farinas, M.M.6    Gonzales, B.S.7    Acosta, D.A.8
  • 89
    • 59949091085 scopus 로고    scopus 로고
    • Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential
    • Sardinas G, Yero D, Climent Y, Caballero E, Cobas K, Niebla O. 2009. Neisseria meningitidis antigen NMB0088: sequence variability, protein topology and vaccine potential. J. Med. Microbiol. 58:196-208. http://dx.doi.org/10.1099/jmm.0.004820-0.
    • (2009) J. Med. Microbiol. , vol.58 , pp. 196-208
    • Sardinas, G.1    Yero, D.2    Climent, Y.3    Caballero, E.4    Cobas, K.5    Niebla, O.6
  • 90
    • 28644439710 scopus 로고    scopus 로고
    • Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant
    • Sardinas G, Reddin K, Pajon R, Gorringe A. 2006. Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant. Vaccine 24:206-214. http://dx.doi.org/10.1016/j.vaccine.2005.07.064.
    • (2006) Vaccine , vol.24 , pp. 206-214
    • Sardinas, G.1    Reddin, K.2    Pajon, R.3    Gorringe, A.4
  • 91
    • 0033523063 scopus 로고    scopus 로고
    • The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci
    • Toropainen M, Kayhty H, Saarinen L, Rosenqvist E, Hoiby EA, Wedege E, Michaelsen T, Makela PH. 1999. The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci. Vaccine 17:2677-2689. http://dx.doi.org/10.1016/S0264-410X(99)00049-3.
    • (1999) Vaccine , vol.17 , pp. 2677-2689
    • Toropainen, M.1    Kayhty, H.2    Saarinen, L.3    Rosenqvist, E.4    Hoiby, E.A.5    Wedege, E.6    Michaelsen, T.7    Makela, P.H.8
  • 92
    • 77249115642 scopus 로고    scopus 로고
    • Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection
    • Seib KL, Oriente F, Adu-Bobie J, Montanari P, Ferlicca F, Giuliani MM, Rappuoli R, Pizza M, Delany I. 2010. Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection. Vaccine 28:2416-2427. http://dx.doi.org/10.1016/j.vaccine.2009.12.082.
    • (2010) Vaccine , vol.28 , pp. 2416-2427
    • Seib, K.L.1    Oriente, F.2    Adu-Bobie, J.3    Montanari, P.4    Ferlicca, F.5    Giuliani, M.M.6    Rappuoli, R.7    Pizza, M.8    Delany, I.9
  • 93
    • 19344376657 scopus 로고    scopus 로고
    • Available carbon source influences the resistance of Neisseria meningitidis against complement
    • Exley RM, Shaw J, Mowe E, Sun YH, West NP, Williamson M, Botto M, Smith H, Tang CM. 2005. Available carbon source influences the resistance of Neisseria meningitidis against complement. J. Exp. Med. 201:1637-1645. http://dx.doi.org/10.1084/jem.20041548.
    • (2005) J. Exp. Med. , vol.201 , pp. 1637-1645
    • Exley, R.M.1    Shaw, J.2    Mowe, E.3    Sun, Y.H.4    West, N.P.5    Williamson, M.6    Botto, M.7    Smith, H.8    Tang, C.M.9
  • 95
    • 58149199760 scopus 로고    scopus 로고
    • Naturally occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures
    • Jakel A, Plested JS, Hoe JC, Makepeace K, Gidney MA, Lacelle S, St Michael F, Cox AD, Richards JC, Moxon ER. 2008. Naturally occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures. Vaccine 26:6655-6663. http://dx.doi.org/10.1016/j.vaccine.2008.09.041.
    • (2008) Vaccine , vol.26 , pp. 6655-6663
    • Jakel, A.1    Plested, J.S.2    Hoe, J.C.3    Makepeace, K.4    Gidney, M.A.5    Lacelle, S.6    St Michael, F.7    Cox, A.D.8    Richards, J.C.9    Moxon, E.R.10
  • 96
    • 0037380691 scopus 로고    scopus 로고
    • Neisseria meningitidis RTX proteins are not required for virulence in infant rats
    • Forman S, Linhartova I, Osicka R, Nassif X, Sebo P, Pelicic V. 2003. Neisseria meningitidis RTX proteins are not required for virulence in infant rats. Infect. Immun. 71:2253-2257. http://dx.doi.org/10.1128/IAI.71.4.2253-2257.2003.
    • (2003) Infect. Immun. , vol.71 , pp. 2253-2257
    • Forman, S.1    Linhartova, I.2    Osicka, R.3    Nassif, X.4    Sebo, P.5    Pelicic, V.6
  • 97
    • 0034062859 scopus 로고    scopus 로고
    • Molecular and biological analysis of eight genetic islands that distinguish Neisseria meningitidis from the closely related pathogen Neisseria gonorrhoeae
    • Klee SR, Nassif X, Kusecek B, Merker P, Beretti JL, Achtman M, Tinsley CR. 2000. Molecular and biological analysis of eight genetic islands that distinguish Neisseria meningitidis from the closely related pathogen Neisseria gonorrhoeae. Infect. Immun. 68:2082-2095. http://dx.doi.org/10.1128/IAI.68.4.2082-2095.2000.
    • (2000) Infect. Immun. , vol.68 , pp. 2082-2095
    • Klee, S.R.1    Nassif, X.2    Kusecek, B.3    Merker, P.4    Beretti, J.L.5    Achtman, M.6    Tinsley, C.R.7
  • 98
    • 0028893659 scopus 로고
    • Considerations on the use of class 5 proteins as meningococcal BC vaccine components
    • Sacchi CT, Gorla MC, de Lemos AP, Brandileone MC. 1995. Considerations on the use of class 5 proteins as meningococcal BC vaccine components. Vaccine 13:112-118. http://dx.doi.org/10.1016/0264-410X (95)80021-5.
    • (1995) Vaccine , vol.13 , pp. 112-118
    • Sacchi, C.T.1    Gorla, M.C.2    de Lemos, A.P.3    Brandileone, M.C.4
  • 99
    • 23244453502 scopus 로고    scopus 로고
    • Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870
    • Hou VC, Koeberling O, Welsch JA, Granoff DM. 2005. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870. J. Infect. Dis. 192:580-590. http://dx.doi.org/10.1086/432102.
    • (2005) J. Infect. Dis. , vol.192 , pp. 580-590
    • Hou, V.C.1    Koeberling, O.2    Welsch, J.A.3    Granoff, D.M.4
  • 100
    • 84864815548 scopus 로고    scopus 로고
    • Loss of meningococcal PilU delays microcolony formation and attenuates virulence in vivo
    • Eriksson J, Eriksson OS, Jonsson AB. 2012. Loss of meningococcal PilU delays microcolony formation and attenuates virulence in vivo. Infect. Immun. 80:2538-2547. http://dx.doi.org/10.1128/IAI.06354-11.
    • (2012) Infect. Immun. , vol.80 , pp. 2538-2547
    • Eriksson, J.1    Eriksson, O.S.2    Jonsson, A.B.3
  • 102
    • 31844433619 scopus 로고    scopus 로고
    • Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis
    • Plant L, Sundqvist J, Zughaier S, Lovkvist L, Stephens DS, Jonsson AB. 2006. Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis. Infect. Immun. 74:1360-1367. http://dx.doi.org/10.1128/IAI.74.2.1360-1367.2006.
    • (2006) Infect. Immun. , vol.74 , pp. 1360-1367
    • Plant, L.1    Sundqvist, J.2    Zughaier, S.3    Lovkvist, L.4    Stephens, D.S.5    Jonsson, A.B.6
  • 104
    • 0032954440 scopus 로고    scopus 로고
    • Structural and evolutionary inference from molecular variation in Neisseria porins
    • Derrick JP, Urwin R, Suker J, Feavers IM, Maiden MC. 1999. Structural and evolutionary inference from molecular variation in Neisseria porins. Infect. Immun. 67:2406-2413.
    • (1999) Infect. Immun. , vol.67 , pp. 2406-2413
    • Derrick, J.P.1    Urwin, R.2    Suker, J.3    Feavers, I.M.4    Maiden, M.C.5
  • 105
    • 0018396839 scopus 로고
    • Serum complement levels in infancy: age related changes
    • Davis CA, Vallota EH, Forristal J. 1979. Serum complement levels in infancy: age related changes. Pediatr. Res. 13:1043-1046. http://dx.doi.org/10.1203/00006450-197909000-00019.
    • (1979) Pediatr. Res. , vol.13 , pp. 1043-1046
    • Davis, C.A.1    Vallota, E.H.2    Forristal, J.3
  • 106
    • 0242574494 scopus 로고    scopus 로고
    • Ontogeny of complement regulatory proteins-concentrations of factor H, factor I, c4b-binding protein, properdin and vitronectin in healthy children of different ages and in adults
    • de Paula PF, Barbosa JE, Junior PR, Ferriani VP, Latorre MR, Nudelman V, Isaac L. 2003. Ontogeny of complement regulatory proteins-concentrations of factor H, factor I, c4b-binding protein, properdin and vitronectin in healthy children of different ages and in adults. Scand. J. Immunol. 58:572-577. http://dx.doi.org/10.1046/j.1365-3083.2003.01326.x.
    • (2003) Scand. J. Immunol. , vol.58 , pp. 572-577
    • de Paula, P.F.1    Barbosa, J.E.2    Junior, P.R.3    Ferriani, V.P.4    Latorre, M.R.5    Nudelman, V.6    Isaac, L.7
  • 107
    • 0016615474 scopus 로고
    • The alternative pathway of complement activation in the neonate
    • Feinstein PA, Kaplan SR. 1975. The alternative pathway of complement activation in the neonate. Pediatr. Res. 9:803-806. http://dx.doi.org/10.1203/00006450-197510000-00012.
    • (1975) Pediatr. Res. , vol.9 , pp. 803-806
    • Feinstein, P.A.1    Kaplan, S.R.2
  • 108
    • 0000719411 scopus 로고
    • The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena
    • Pillemer L, Blum L, Lepow IH, Ross OA, Todd EW, Wardlaw AC. 1954. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120:279-285.
    • (1954) Science , vol.120 , pp. 279-285
    • Pillemer, L.1    Blum, L.2    Lepow, I.H.3    Ross, O.A.4    Todd, E.W.5    Wardlaw, A.C.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.